期刊文献+

对肝硬化腹水进行净化并超滤浓缩的实验研究

Study on endotoxin and bilirubin removal by CA/PEI affinity membrane and protein ultrafiltration by polysulfone hollow fiber membrane in ascites of cirrhosis
下载PDF
导出
摘要 [目的]净化和优化肝硬化腹水使其更有利于浓缩回输治疗。[方法]采用CA/PEI亲和膜去除腹水胆红素、内毒素,并采用聚砜中空纤维膜超滤浓缩腹水,用内毒素测定仪、生化自动分析仪和免疫分析仪测定过膜前后各项指标。[结果]CA/PEI亲和膜吸咐前后腹水中的胆红素、内毒素均明显下降(P〈0.01);胆红素吸附前(51.77±11.76)μmol/L;吸附后(21.18±6.83)μmol/L;内毒素吸附前(3.777±0.233)EU/mL,吸附后(0.341±0.322)EU/mL。白蛋白、离子、免疫球蛋白均无明显变化(P〉0.05)。腹水超滤浓缩5.5~6.5倍,蛋白质浓缩4.7~6.5倍,免疫球蛋白浓缩3倍,但离子无变化。[结论]用CA/PEI亲和膜可去除胆红素、内毒素,用聚砜中空纤维膜超滤浓缩能使腹水得到净化和蛋白浓缩。 [Objective] Purification and optimization of cirrhotic ascites is more helpful to reinfusion and treatment of ascites.[Methods] Endotoxin and bilirubin removal by CA/PEI affinity membrane and protein ultrafiltration by polysulfone hollow fiber membrane in ascites of cirrhosis were studied.The indexes of pre and post trans-membrane by endotoxin detector,biochemistry analyzer and immunity analyzer were measured.[Results] The endotoxin and bilirubin concentration in ascites were reduced with adsorption by CA/PEI affinity membrane(P〈0.01).There were unchanged in albumin,ion and immunoglobulin(P〉0.05).Before adsorptioned bilirubin is(51.77±11.76)μmol/L,after which is(21.18±6.83)μmol/L.Before adsorptioned endotoxin is(3.777±0.233)EU/mL,after which is(0.341±0.322)EU/mL.Ascites were concentrated 5.5 to 6.5 times by ultrafiltration,while the protein in ascites was concentrated 4.7 to 6.5 times and immunoglobulin was concentrated more than 3 times and ions were no change.[Conclusion] Ascites of purification and protein concentration may be obtained by the way of removal endotoxin and bilirubin with CA/PEI affinity membrane and ultrafiltration and concentration with polysulfone hollow fiber membrane.
出处 《大连医科大学学报》 CAS 2009年第5期513-515,518,共4页 Journal of Dalian Medical University
基金 国家自然科学基金项目(30570515) 教育部留学回国人员科研启动基金([2005]546) 辽宁省自然科学基金项目(20061058) 辽宁省教育厅项目(2004F063)
关键词 CA/PEI亲和膜 中空纤维膜 内毒素 胆红素 浓缩 CA/PEI affinity membrane hollow fiber membrane endotoxin bilirubin concentration
  • 相关文献

参考文献11

二级参考文献47

  • 1龚德华,季大玺,徐斌,任冰,刘云,黎磊石.以血浆作透析液治疗高胆红素血症的效果[J].肾脏病与透析肾移植杂志,2004,13(3):201-204. 被引量:16
  • 2Hui-Ying Zhang,De-Wu Han,Zhong-Fu Zhao,Ming-She Liu,Yan-Jun Wu,Xian-Ming Chen,Cheng Ji.Multiple pathogenic factor-induced complications of cirrhosis in rats: A new model of hepatopulmonary syndrome with intestinal endotoxemia[J].World Journal of Gastroenterology,2007,13(25):3500-3507. 被引量:37
  • 3高寿征 田庚善 崔振宇主编.病毒性肝炎防治研究[M].北京:北京出版社,1995.177-178.
  • 4Watanabe FD, Mullon CJ, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg, 1997, 225: 484-491.
  • 5Sussman NL, Gislason GT, Kelly JH. Extracorporeal liver support.application to fulminaot hepatic failure. J Clin Gastroenterol, 1994,18: 320-324.
  • 6Gerlach JC, Lemmens P, Schon M, et al. Experimental evaluation of a hybrid liver support system. Transplant Proc, 1997, 29: 852.
  • 7Demetriou AA, Rozga J, Podesta L, et al. Early clinical experience with a hybrid bioartificial liver. Scand J Gastroenterol, 1995, 208:111-117.
  • 8McLaughlin BE, Tosone CM, Custer LM, et al. Overview of extracorporeal liver support systems and clinical results. Ann N Y Acad Sci, 1999, 875: 310-325.
  • 9Maddrey WE. Bioartificial liver in the treatment of hepatic failure.Liver Transplant, 2000, 6: S27-S30.
  • 10Gerlach J. Special issue: hybrid liver support. Int J Artif Organs,1996, 19: 1-2.

共引文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部